Bronchial Diseases Recruiting Phase 3 Trials for Fevipiprant (DB12011)

Also known as: Bronchial Disease

IndicationStatusPhase
DBCOND0042791 (Bronchial Diseases)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03681093Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and AsthmaTreatment
NCT03629249Systemic Corticosteroids Avoidance Study in Severe Asthma PatientsTreatment